Printer Friendly

CAMBRIDGE BIOTECH CORPORATION DISPUTES ALLEGATIONS IN COMPLAINT

 WORCESTER, Mass., Nov. 17 /PRNewswire/ -- Cambridge Biotech Corporation (NASDAQ: CBCX) has received a copy of a complaint filed by one of its shareholders seeking class certification. In the company's opinion, certain factual allegations on which the claims are based are inaccurate, and the company intends to vigorously defend the suit. On advice of counsel, the company will not comment further at this time.
 Cambridge Biotech Corporation is a leading diagnostics and therapeutics company involved in infectious diseases. The company is developing vaccines, adjuvants, and diagnostics for humans and animals.
 -0- 11/17/93
 /CONTACT: Frederick V. Casselman, vice president, legal affairs and technology licensing of Cambridge Biotech Corp., 508-797-5777, ext. 507/
 (CBCX)


CO: Cambridge BioTech Corporation ST: Massachusetts IN: MTC SU:

JL-DJ -- NE019 -- 5734 11/17/93 17:30 EST
COPYRIGHT 1993 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1993 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Nov 17, 1993
Words:130
Previous Article:AMERICAN NUCLEAR TO SELL URANIUM PROPERTIES
Next Article:STARLOG STORMS INTO GARDEN STATE PLAZA MALL
Topics:

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters